Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Throughput Nucleotide Sequencing × CNS × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Sarcoma 2 Gynecologic 1 CNS 1 Breast 1

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

Temozolomide 145 Magnetic Resonance Spectroscopy 112 Radiotherapy 84 Specimen Handling 74 Radiosurgery 62 pembrolizumab 48 Cyclophosphamide 46 Nivolumab 45 Radiation 43 Bevacizumab 35 Carboplatin 29 Biopsy 28 Irinotecan 22 Ipilimumab 22 Etoposide 22 Blood Specimen Collection 20 Cisplatin 19 dinutuximab 18 Vincristine 18 Lomustine 18 Radiotherapy, Intensity-Modulated 17 X-Rays 16 Surgical Procedures, Operative 16 Topotecan 15 Pemetrexed 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 fludarabine 14 abemaciclib 14 sargramostim 13 atezolizumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡